Neoplasia Clinical Trial
Official title:
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces. It is hypothesized that sniff dogs may be used as a tool in identifying cancer patients in the high risk population or suspected patients. Trained dogs will sniff serum from participants who are suspected to suffer from tumor by their physicians and not yet but will be diagnosed by pathological examination.The results will be compared with the outcome of the pathological examination.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | December 2026 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 1 Year and older |
Eligibility | Inclusion Criteria: - Healthy volunteers who have been examined by the currently used procedures and find to be without tumors. - Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors Exclusion Criteria: - Patients who have had pathological results |
Country | Name | City | State |
---|---|---|---|
China | Center for Scientific Research with Animal Models, CSU | Changsha | Hunan |
Lead Sponsor | Collaborator |
---|---|
Chang-Qing Gao |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | the substances used for identifying tumors by the sniff dogs | GCMS etc will be used to compare the volatile compounds between the sera from cancers patients and the from non-cancer subjects, the suspected VOCs will be tested by the dog for conformation. | 12 months | |
Primary | sensitivity and specificity of the sniff dogs as a tool in diagnosing tumors | The results that obtained from the dogs will be compared with these of the pathological examinations. Sensitivity = the No. of patients identified by the dogs as cancers / the No. of patients suffering from cancer confirmed by pathological examination. Specificity = No. of subjects signaled by the dog as non-cancers / No. of subjects confirmed by pathological examination as non-cancer subjects. | 12 months | |
Secondary | behavior patterns of the sniff dogs to different diseases | The behavior (lying before the tank for positive, neglecting the tanks) of the dog will be recorded and compared with the results of the pathological examination. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00339989 -
Cervical Cancer Early Endpoints and Determinants
|
||
Completed |
NCT01954836 -
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
|
N/A | |
Not yet recruiting |
NCT03979014 -
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial
|
Phase 3 | |
Completed |
NCT02065297 -
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
|
||
Recruiting |
NCT02049645 -
The Suitability of Sniff Dog as a Tool in Screening Tumors
|
||
Completed |
NCT01523912 -
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
|
Phase 4 | |
Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
Enrolling by invitation |
NCT00792649 -
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy
|
N/A | |
Recruiting |
NCT05158712 -
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
|
||
Completed |
NCT01962103 -
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT01456143 -
Optical Imaging of Head and Neck Cancer
|
N/A | |
Recruiting |
NCT04341181 -
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
|
Phase 2 | |
Recruiting |
NCT02925234 -
The Drug Rediscovery Protocol (DRUP Trial)
|
Phase 2 |